NeuroOne Med Tech (NASDAQ: NMTC) holder plans 10,000-share sale after March trades
Rhea-AI Filing Summary
Mark A. Christianson filed a Form 144 to sell up to 10,000 shares of Common Stock of NeuroOne Med Tech. The form lists an aggregate amount of $33,400.00 and records multiple sales during March 2026, including 15,363 shares on 03/30/2026 for $11,053.07 and other smaller dispositions earlier in March.
Positive
- None.
Negative
- None.
Insights
Form 144 filed for sale of restricted/controlled shares under Rule 144.
The filing names Mark A. Christianson and lists 10,000 shares to be sold and an aggregate dollar figure of $33,400.00. Several prior March 2026 dispositions are recorded with exact dates and proceeds.
These entries are procedural disclosures of proposed and recent sales; cash‑flow treatment is the selling holder's proceeds. Subsequent filings will disclose actual execution details and amounts sold under this Form 144.
AI-generated analysis. How Rhea-AI works. Not financial advice.